Paradromics Overview
- Founded
- 2015
- Status
- Private
- Employees
- 34
- Latest Deal Type
- Seed
- Latest Deal Amount
- $28.2M
- Investors
- 22
Paradromics General Information
Description
Developer of a data-rate brain-computer interface technology designed to increase the data transmission rate between brains and machines. The company's technology offers high-volume, bidirectional data streaming capabilities between brains and computers, enabling patients with neuro disorders to compensate for the loss of biological connectivity.
Contact Information
Website
www.paradromics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
- 4030 West Braker Lane
- Suite 250
- Austin, TX 78759
- United States
+1 (512) 000-0000
Paradromics Timeline
Paradromics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 18-Oct-2021 | $28.2M | 000.00 | 000.00 | Completed | Pre-Clinical Trials |
| 6. Grant | 14-Oct-2021 | 0000 | 000.00 | Completed | Pre-Clinical Trials | |
| 5. Debt - PPP | 14-Apr-2020 | 00000 | 000.00 | Completed | Pre-Clinical Trials | |
| 4. Debt - General | 15-Apr-2019 | 000 | 000.00 | Completed | Pre-Clinical Trials | |
| 3. Seed Round | 04-May-2018 | 00.000 | 00.000 | 000.00 | Completed | Pre-Clinical Trials |
| 2. Grant | 10-Jul-2017 | $14.2M | Completed | Pre-Clinical Trials | ||
| 1. Grant | 22-Apr-2016 | $798K | Completed | Pre-Clinical Trials |
Paradromics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series Seed 2A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series Seed 2B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | |
| Seed | 5,622,045 | $0.000100 | $1.27 | $1.27 | 1x | $1.17 | 8.44% |
Paradromics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a data-rate brain-computer interface technology designed to increase the data transmission rate between bra
Other Healthcare Technology Systems
Austin, TX
34
As of 2021
000.00
00.00
0000-00-00
000000000
000.00
000000
sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
0000000000 000000000
San Francisco, CA
00
As of 0000
0000
00000000000
0000
00000000
iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
00000 0000000000 0000000000 0000000
San Jose, CA
00
As of 0000
000.00
000000 - 000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialParadromics Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Emotiv | Venture Capital-Backed | San Francisco, CA | 00 | 0000 | 00000000000 | 0000 |
| 00000000 | Formerly VC-backed | San Jose, CA | 00 | 000.00 | 000000 - 000 | 000.00 |
Paradromics Patents
Paradromics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210098341-A1 | Microelectrode array and methods of fabricating same | Pending | 30-Sep-2019 | 000000000 | |
| US-20200046240-A1 | Low-area, low-power neural recording circuit, and method of training the same | Pending | 14-Apr-2017 | 00000000000 | |
| EP-3609397-A1 | Low-area, low-power neural recording circuit, and method of training the same | Pending | 14-Apr-2017 | 00000000 | |
| EP-3609397-A4 | Low-area, low-power neural recording circuit, and method of training the same | Pending | 14-Apr-2017 | 00000000 | 0 |
| US-20180085018-A1 | Systems and methods for splaying microelectrode sensors | Abandoned | 29-Sep-2016 | A61B5/0408 |
Paradromics Executive Team (9)
Paradromics Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adam Kablanian | Self | Board Member | 000 0000 |
| Amy Kruse Ph.D | Prime Movers Lab | Board Member | 000 0000 |
| James Burrows | Paradromics | Chief Operating Officer & Board Member | 000 0000 |
| Matthew Angle Ph.D | Paradromics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Paradromics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialParadromics Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Lateral Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Prime Movers Lab | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Pureland Group | Impact Investing | Minority | 000 0000 | 000000 0 | |
| What If Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| United States Department of Defense | Government | 000 0000 | 000000 0 |